9.64MMarket Cap
LossP/E TTM
Theriva Biologics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Theriva Biologics Inc is 7.14, ranking 209 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.36, which is -136.06% below the recent high of 0.13 and -5825.68% above the recent low of -21.62.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.